IL17A and congenital rubella syndrome: The pro‐inflammatory cytokine IL‐17 is a key regulator of type III inflammation and in addition to CRS has been implicated in several diseases characterized by chronic inflammation, including psoriasis, rheumatoid arthritis, and asthma [4].